Researchers identify neurotransmitter that helps cancers progress

by Johns Hopkins University School of MedicineUsing human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotrans

Updated on: June 15,2024

Researchers identify neurotransmitter that helps cancers progress

by Johns Hopkins University School of MedicineUsing human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotrans

Updated on:June 15,2024

Researchers develop tool that reduces errors in stem cell transplant reporting

by Children's Hospital of PhiladelphiaCredit: CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determinatio

Updated on: February 20,2024

Researchers develop tool that reduces errors in stem cell transplant reporting

by Children's Hospital of PhiladelphiaCredit: CC0 Public DomainResearchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determinatio

Updated on:February 20,2024

Next milestone in the treatment of liver tumors and acute and chronic liver diseases

by Bianca Hermle, Universitätsklinikum TübingenGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.02.023The results of a Tübingen-led study raise hope that a newly developed d

Updated on: March 20,2024

Next milestone in the treatment of liver tumors and acute and chronic liver diseases

by Bianca Hermle, Universitätsklinikum TübingenGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.02.023The results of a Tübingen-led study raise hope that a newly developed d

Updated on:March 20,2024

Resetting the epigenetic balance for cancer therapy

by Will Doss,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHThough mutations in a gene called MLL3 are common across many types of cancers, their relationship to the de

Updated on: April 07,2024

Resetting the epigenetic balance for cancer therapy

by Will Doss,Northwestern UniversityKiller T cells surround a cancer cell. Credit: NIHThough mutations in a gene called MLL3 are common across many types of cancers, their relationship to the de

Updated on:April 07,2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on: October 10,2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on:October 10,2024

Discovery could lead to new drugs to block protein that fuels bowel cancer

by Institute of Cancer ResearchUsing cryo-electron microscopy, researchers obtained a detailed map (shown in orange) of the chain-like tankyrase structure. By interpreting this map and reconstruc

Updated on: February 23,2024

Discovery could lead to new drugs to block protein that fuels bowel cancer

by Institute of Cancer ResearchUsing cryo-electron microscopy, researchers obtained a detailed map (shown in orange) of the chain-like tankyrase structure. By interpreting this map and reconstruc

Updated on:February 23,2024

A chemistry pioneer works to improve a flawed test for a common cancer

by Clare Milliken,Northwestern UniversityKelleher says top-down proteomics provides a more comprehensiveunderstanding of human proteins than bottom-up proteomics, which is both imprecise a

Updated on: May 23,2024

A chemistry pioneer works to improve a flawed test for a common cancer

by Clare Milliken,Northwestern UniversityKelleher says top-down proteomics provides a more comprehensiveunderstanding of human proteins than bottom-up proteomics, which is both imprecise a

Updated on:May 23,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on: March 12,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on:March 12,2024

Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in theInternational Journ

Updated on: January 02,2024

Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in theInternational Journ

Updated on:January 02,2024

HPV vaccine eliminates advanced skin cancer in 97-year-old

(HealthDay)—The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a

Updated on: March 12,2024

HPV vaccine eliminates advanced skin cancer in 97-year-old

(HealthDay)—The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a

Updated on:March 12,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A

Updated on: May 25,2024

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A

Updated on:May 25,2024